Physician profile
Naveen Anand
NPI 1841474541
$5,726.80
in general payments reported to CMS, 2019-2025
13 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $29.97 · 2021: $174 · 2022: $1,125 · 2023: $1,374 · 2024: $1,419 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179 · Travel and Lodging: $1,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,179.37 |
| Travel and Lodging | $1,936.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,803.95 | 2022-2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment |
| Boston Scientific Corporation | $1,289.89 | 2019-2025 | Exalt Model D, General - Polypectomy, Axios |
| Ovesco Endoscopy USA, INC. | $647.32 | 2023 | |
| Cook Medical LLC | $488.68 | 2020-2025 | Echotip Insight, Echotip |
| Medtronic, INC. | $483.54 | 2022-2025 | Nexpowder, Prodigi |
| Omega Medical Imaging, LLC | $296.91 | 2025 | |
| Olympus America INC. | $179.06 | 2019-2022 | |
| Creo Medical INC. | $177.57 | 2024 | Speedboat Ultraslim (Sb1l) |
| Astrazeneca Pharmaceuticals LP | $131.35 | 2025 | |
| Micro-Tech Endoscopy USA, INC. | $101.73 | 2025 | Eyemax |
| Abbvie INC. | $78.28 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.30 | 2024 | Eohilia |
| Janssen Biotech, INC. | $15.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.